Utility of Some Novel Biomarkers of Patients With Chronic Heart Failure
ConditionHeart Failure
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorSherief Abd-Elsalam
About this trial
Clinical and Economic study of some new biomarkers in chronic heart failure.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
NYHA-Class II-IV
Disqualifiers
Liver or renal dysfunction. --DM
Trial design
Design model
Parallel
Treatments tested in this trial
New york Heart Association Class II-IV
Diagnostic testNew york Heart Association Class II-IV " study of markers"
New york Heart Association Class I
Diagnostic testNew york Heart Association Class I
Treatment groups
60 Participants
are divided into 2 treatment groupsGroup A: New york Heart Association Class II-IVActive comparator 1 intervention
Group B: New york Heart Association Class IActive comparator 1 intervention
Trial outcomes
Primary outcomes
1
Number of participants with elevated markers (IL17)
Number of participants with elevated markers (IL17)
Time frame
6 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Sherief Abd-Elsalam
Lead sponsor
Tanta University
Sponsor institution
Source ClinicalTrials.gov